Skip to content Open menu

Swiss Vascular Technology Featured in Dynabot Research
July 30, 2026

Swiss Vascular Technology Featured in Dynabot Research

A new bioRxiv preprint presents dynamic nanoparticle-based biomedical microrobots for targeted drug delivery. The study demonstrates magnetic navigation and real-time fluoroscopic guidance in anatomically realistic phantoms, as well as in vivo models. Swiss Vascular co-founders Fabian Landers and Pascal Theiler contributed to the work.